-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (CST-2032 + Nadolol) in Dementia
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.(CST-2032 + Nadolol) in Dementia Drug Details: A fixed-dose combination of CST-2032 and nadolol (CST-107) is...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – CST-2140 in Orthostatic Hypotension
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. CST-2140 in Orthostatic Hypotension Drug Details: CST-2140 is under development for the treatment of Parkinsonism...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (CST-2032 + Nadolol) in Mild Cognitive Impairment
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (CST-2032 + Nadolol) in Mild Cognitive Impairment Drug Details: A fixed-dose combination of CST-2032 and...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (CST-2032 + Nadolol) in Dementia Associated With Alzheimer’s Disease
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (CST-2032 + Nadolol) in Dementia Associated With Alzheimer's Disease Drug Details: A fixed-dose combination of...
-
Product Insights
Forderverein Cargo – CST Freight Metro Tunnel – Zurich
Equip yourself with the essential tools needed to make informed and profitable decisions with our Forderverein Cargo - CST Freight Metro Tunnel - Zurich report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
CST Land Dev – The Reserve at Howell Place – Louisiana
Equip yourself with the essential tools needed to make informed and profitable decisions with our CST Land Dev - The Reserve at Howell Place - Louisiana report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Clenbuterol Hydrochloride + Nadolol) in Parkinson’s Disease
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.(Clenbuterol Hydrochloride + Nadolol) in Parkinson's Disease Drug Details: A fixed dose combination of clenbuterol hydrochloride...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Clenbuterol Hydrochloride + Nadolol) in Mild Cognitive Impairment
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.(Clenbuterol Hydrochloride + Nadolol) in Mild Cognitive Impairment Drug Details: A fixed dose combination of clenbuterol...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Clenbuterol Hydrochloride + Nadolol) in Lewy Body Dementia
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.(Clenbuterol Hydrochloride + Nadolol) in Lewy Body Dementia Drug Details: A fixed dose combination of clenbuterol...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Cellular Immunotherapy 2 For Oncology And Coronavirus Disease 2019 (Covid-19) in Solid Tumor
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Cellular Immunotherapy 2 for Oncology and Coronavirus Disease 2019 (COVID-19) in Solid Tumor Drug...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TI-1007 in B-Cell Non-Hodgkin Lymphoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.TI-1007 in B-Cell Non-Hodgkin LymphomaDrug Details:TI-1007 is under development for the treatment of relapsed and refractory...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – PF-07265028 in Gastric Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.PF-07265028 in Gastric Cancer Drug Details:PF-07265028 is under development for the treatment of advanced solid tumors, gastric...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – CRG-022 in Refractory Chronic Lymphocytic Leukemia (CLL)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.CRG-022 in Refractory Chronic Lymphocytic Leukemia (CLL)Drug Details:CRG-022 is under development for the treatment of pediatric,...
-
Sector Analysis
Canada Statutory and Private Employee Benefits, 2023 Update
Canada Statutory and Private Employee Benefits Market Overview The Canadian social security system covers various programs, many of which are run by the country’s provinces and territories. In general, benefits are similar across all provinces and territories; however, Quebec implements its pension plan. The government provides financial support to provincial and territorial governments through four main transfer programs – the Canada Health Transfer (CHT), the Canada Social Transfer (CST), and Equalization and Territorial Formula Financing (TFF)–to help them provide social...
-
Company Profile
![]()
Cheng Shin Rubber Industry Co Ltd – Company Profile
Cheng Shin Rubber Industry Co Ltd (Cheng Shin) is a manufacturer of rubber tires. The company process, manufactures, markets and distributes various tyres and related products. Cheng Shin’s product portfolio includes electrical vehicle tires, bicycle tires, reclaimed rubber, various rubbers and resign other rubber products. The company also manufactures and markets relevant rubber machinery. Cheng Shin offers tires and tubes for motorcycles, all-terrain vehicles, autos, trucks, forklifts, agricultural and lawn and garden equipment. The CST brand is sold in more...
Add to Basket -
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – (CST-2032 + nadolol)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry (CST-2032 + nadolol) Drug Details A fixed-dose combination of CST-2032 and nadolol (CST-107) is...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – Cellular Immunotherapy 2 for Oncology and Coronavirus Disease 2019 (COVID-19)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry Cellular Immunotherapy 2 for Oncology and Coronavirus Disease 2019 (COVID-19) Drug Details Cellular immunotherapy...
-
Product Insights
Blood Purification Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021
Blood Purification Equipment is to filter blood by removing the irreversibly damaged red blood cells and toxins before transfusion and reduces the occurrence of post-transfusion complications. The report provides comprehensive information about the blood purification equipment pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Product Insights
Grande Cache Coal Mine
The Grande Cache Coal Mine is a Coal mine in Canada. It is currently in operation. Grande Cache Coal Mine profile includes core details such as name, commodity, ore type, stage, type, owner and equity stakes, operator, size and location, as well as key operational data including production, capacity, strip ratio, start and end date, reserves and resources, grade. We also provide proprietary production forecasts, and counts of mobile equipment, plus selected key stakeholders and contact details.
-
Sector Analysis
Global LNG Industry Outlook to 2021 – Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Terminals
Global LNG Industry Outlook to 2021 – Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Terminals is a comprehensive report on the global LNG industry. The report provides key asset details of all active and planned, LNG liquefaction and regasification terminals in the world by region and country. Information by terminal includes terminal name, operator name and design LNG processing capacity (liquefaction / regasification) for the period 2011–2021. Planned (new build) LNG terminals capacity additions and...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.